✦ LIBER ✦

A Phase I and Pharmacodynamic Study of AT9283, a Small-Molecule Inhibitor of Aurora Kinases in Patients With Relapsed/Refractory Leukemia or Myelofibrosis

✍ Scribed by Foran, James; Ravandi, Farhad; Wierda, William; Garcia-Manero, Guillermo; Verstovsek, Srdan; Kadia, Tapan; Burger, Jan; Yule, Murray; Langford, Gillian; Lyons, John; Ayrton, John; Lock, Victoria; Borthakur, Gautham; Cortes, Jorge; Kantarjian, Hagop

Book ID: 122118385
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 550 KB
Volume: 14
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacodynamic study of s

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia

✍ Brenda W Cooper; Erin Donaher; Hillard M Lazarus; Sylvan B Green; David M Gosky; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 863 KB

285 POSTER AT7519, a selective small mol

285 POSTER AT7519, a selective small molecule inhibitor of cyclin dependent kinases: pharmacodynamic biomarker activity in a Phase I study

✍ J. Lyons; P. Sweeney; V. Lock; M. Squires; N. Thompson; N. Gallagher 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase I study of MLN8237—investigational

Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia

✍ Kelly, Kevin R.; Shea, Thomas C.; Goy, André; Berdeja, Jesus G.; Reeder, Craig B 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 542 KB

Phase I Study of Temozolomide and Laromu

Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia

✍ David Rizzieri; Samantha LoRusso; William Tse; Khuda Khan; Anjali Advani; Joseph 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 123 KB

Phase I and II pharmacokinetic and pharm

Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma

✍ Yoshiaki Ogawa; Kensei Tobinai; Michinori Ogura; Kiyoshi Ando; Takahide Tsuchiya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

A Phase I Study of Fludarabine, Cytarabi

A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

✍ Tsimberidou, Apostolia Maria; Keating, Michael J.; Jabbour, Elias J.; Ravandi-Ka 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 208 KB